Back to Search Results
Image Place holder

Bruce Wenig, MD

Department Chair, Pathology

 
Specialty: Pathology
Program: Pathology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Adrenal Carcinoma, Head and Neck Cancer, Oral Cavity or Throat Cancer, Thyroid Cancer

Dr. Bruce Wenig is a Senior Member in the Department of Anatomic Pathology at Moffitt Cancer Center. Dr. Wenig also serves as the Section Head of Anatomic Pathology External Network Consultation Services and the Section Head of Moffitt’s Head and Neck–Endocrine Pathology Program. Dr. Wenig received his MD from Sackler School of Medicine/New York State Division at the Tel Aviv University in Israel. He completed an Anatomic and Clinical Pathology Residency in the Department of Pathology at The Mount Sinai Medical Center, New York. Dr. Wenig completed a Fellowship in Surgical Pathology in the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, Los Angeles, California, and a Fellowship in Otolaryngic Pathology at the Armed Forces Institute of Pathology in Washington, DC. Following his Fellowship, Dr. Wenig was a Staff Pathologist (1987-1998) for the Department of Otolaryngic-Endocrine Pathology at the Armed Forces Institute of Pathology, and also served as Chief, Division of Otolaryngic Pathology, Department of Endocrine and Otorhinolaryngic Head and Neck Pathology, Washington, DC. From 1998 to 2001, Dr. Wenig was the Vice Chairman for Anatomic Pathology and Professor of Pathology, Department of Pathology at Albert Einstein College of Medicine, Bronx, NY. From 2001 to 2003, he was Vice Chairman for Anatomic Pathology, Department of Pathology and Laboratory Medicine at Beth Israel Medical Center, St. Luke’s – Roosevelt Hospitals, New York, NY, and Associate Director, Continuum Cancer Center of New York. Prior to joining Moffitt, he was the Chairman, Department of Diagnostic Pathology and Laboratory Medicine, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai Roosevelt, New York; Vice Chairman of Anatomic Pathology, Department of Pathology, Mount Sinai Health System, NY; and Professor of Pathology, Department of Pathology, Icahn School of Medicine, Mount Sinai, NY. Dr. Wenig’s main clinical interests are in diseases of the head and neck and of endocrine organs including oncologic and non-neoplastic diseases. He has published extensively in peer-reviewed journals as well as authoring/editing several textbooks and numerous book chapters on head-and-neck and endocrine pathology. The third edition of his singly authored book, The Atlas of Head and Neck Pathology, was published in 2016. His research is primarily clinically focused, utilizing classic morphology in conjunction with immunohistochemical and molecular biologic techniques in the evaluation of a wide spectrum of diseases of the head and neck and of the endocrine organs. 


Education & Training

Fellowship:

  • Cedars-Sinai Medical Center - Anatomic Pathology
  • Amred Forces Institute of Pathology - Otolaryngic Pathology

Residency:

  • The Mount Sinai Medical Center - Anatomic Pathology

Medical School:

  • Sackler School of Medicine/NY Division at Tel Aviv University - MD
Video Profile
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • McLean-Holden AC, Rooper LM, Lubin DJ, Magliocca KR, Manucha V, Sadow PM, Tobias J, Vargo RJ, Thompson LDR, Heidarian A, Weinreb I, Wenig B, Gagan J, Hernandez-Prera JC, Bishop JA. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology. Head Neck Pathol. 2022 Sep.16(3):657-669. Pubmedid: 34985683. Pmcid: PMC9424381.
  • Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol. 2022 Mar.16(1):123-142. Pubmedid: 35312985. Pmcid: PMC9018952.
  • Hernandez-Prera JC, Saeed-Vafa D, Heidarian A, Gewandter K, Otto K, Wenig BM. Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature. Head Neck Pathol. 2022 Jun.16(2):416-426. Pubmedid: 34410594. Pmcid: PMC9187789.
  • Chung CH, Li J, Steuer CE, Bhateja P, Johnson M, Masannat J, Poole MI, Song F, Hernandez-Prera JC, Molina H, Wenig BM, Kumar S, Kuperwasser C, Stephens PJ, Farinhas JM, Shin DM, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF, Bonomi M. Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2022 Jun.28(11):2329-2338. Pubmedid: 35344035. Pmcid: PMC9167762.
  • Heidarian A, Wenig BM, Hernandez-Prera JC. Evaluation of programmed death ligand 1 immunohistochemistry in cytology specimens of head and neck squamous cell carcinoma. Cancer Cytopathol. 2022 Feb.130(2):91-95. Pubmedid: 34411441.
  • Rooper LM, Bishop JA, Faquin WC, Foss RD, Gallia GL, Jo VY, Lewis JS, Nishino M, Stelow EB, Thompson LDR, Wenig BM, Westra WH. Sinonasal Tumors With Neuroepithelial Differentiation (Olfactory Carcinoma): Delineation of Their Pathologic and Clinical Features With Insights into Their Relationship to Olfactory Neuroblastoma and Sinonasal Carcinoma. Am J Surg Pathol. 2022 Aug.46(8):1025-1035. Pubmedid: 35420559.
  • Hernandez-Prera JC, Skálová A, Franchi A, Rinaldo A, Vander Poorten V, Zbären P, Ferlito A, Wenig BM. Pleomorphic adenoma: the great mimicker of malignancy. Histopathology. 2021 Sep.79(3):279-290. Pubmedid: 33368685.
  • de la Iglesia JV, Slebos RJC, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell J, Harrison L, Wenig BM, Conejo-Garcia J, Hernandez-Prera JC, Chung CH. Correction: Effects of Tobacco Smoking On the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 Sep.27(17):4941. Pubmedid: 34470812.
  • Heidarian A, Wenig BM. The Most Common Mistake in Laryngeal Pathology and How to Avoid it. Head Neck Pathol. 2021 Mar.15(1):130-137. Pubmedid: 33723761. Pmcid: PMC8010031.
  • Chung CH, Bonomi M, Steuer CE, Li J, Bhateja P, Johnson M, Masannat J, Song F, Hernandez-Prera JC, Wenig BM, Molina H, Farinhas JM, McMullen CP, Wadsworth JT, Patel KB, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers (Basel). 2021 Mar.13(5). Pubmedid: 33803335. Pmcid: PMC7967147.
  • Thompson LDR, Fitzpatrick SG, Müller S, Eisenberg E, Upadhyaya JD, Lingen MW, Vigneswaran N, Woo SB, Bhattacharyya I, Bilodeau EA, Carlos R, Islam MN, Leon ME, Lewis JS, Magliocca KR, Mani H, Mehrad M, Purgina B, Richardson M, Wenig BM, Cohen DM. Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting. Head Neck Pathol. 2021 Jun.15(2):572-587. Pubmedid: 33415517. Pmcid: PMC8134585.
  • Hernandez-Prera J, Valderrabano P, Creed J, de la Iglesia JV, Slebos R, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder S, Lam C, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2021 Jan.31(1):36-49. Pubmedid: 32689909. Pmcid: PMC7864115.
  • Asa SL, Arkun K, Tischler AS, Qamar A, Deng FM, Perez-Ordonez B, Weinreb I, Bishop JA, Wenig BM, Mete O. Middle Ear "Adenoma": a Neuroendocrine Tumor with Predominant L Cell Differentiation. Endocr Pathol. 2021 Dec.32(4):433-441. Pubmedid: 34041698.
  • de la Iglesia JV, Slebos RJ, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, Van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell JJ, Harrison LB, Wenig B, Conejo-Garcia JR, Hernandez-Prera JC, Chung CH. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2020 Mar.26(6):1474-1485. Pubmedid: 31848186. Pmcid: PMC7073297.
  • Shah AA, Jain D, Ababneh E, Agaimy A, Hoschar AP, Griffith CC, Magliocca KR, Wenig BM, Rooper LM, Bishop JA. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features. Head Neck Pathol. 2020 Jun.14(2):465-472. Pubmedid: 31468350. Pmcid: PMC7235142.
  • Giuliano AR, Nedjai B, Lorincz AT, Schell MJ, Rahman S, Banwait R, Boulware D, Sirak B, Martin-Gomez L, Abrahamsen M, Isaacs-Soriano KA, Wenig B, Chung CH, Caudell J. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics. Int J Cancer. 2020 Feb.146(4):1018-1030. Pubmedid: 31304592. Pmcid: PMC7787351.
  • Gale N, Cardesa A, Hernandez-Prera JC, Slootweg PJ, Wenig BM, Zidar N. Laryngeal Dysplasia: Persisting Dilemmas, Disagreements and Unsolved Problems-A Short Review. Head Neck Pathol. 2020 Dec.14(4):1046-1051. Pubmedid: 32141027. Pmcid: PMC7669915.
  • Xu B, Barbieri AL, Bishop JA, Chiosea SI, Dogan S, Di Palma S, Faquin WC, Ghossein R, Hyrcza M, Jo VY, Lewis JS, Lozada JR, Michal M, Pareja FG, Perez-Ordonez B, Prasad ML, Purgina B, Reis-Filho JS, Scognamiglio T, Sebastiao APM, Seethala RR, Skálová A, Smith SM, Tekkeşin MS, Thompson LDR, Wasseman JK, Wenig BM, Weinreb I, Katabi N. Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study. Am J Surg Pathol. 2020 Apr.44(4):545-552. Pubmedid: 31917707. Pmcid: PMC7437128.
  • Hernandez-Prera JC, Holmes BJ, Valentino A, Harshan M, Bacchi CE, Petersson F, Liu KK, Najfeld V, Wenig BM. Macrocystic (Mammary Analogue) Secretory Carcinoma: An Unusual Variant and a Pitfall in the Differential Diagnosis of Cystic Lesions in the Head and Neck. Am J Surg Pathol. 2019 Nov.43(11):1483-1492. Pubmedid: 31464708.
  • Gupta R, Sandison A, Wenig BM, Thompson LDR. Data Set for the Reporting of Ear and Temporal Bone Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2019 May.143(5):593-602. Pubmedid: 30500288.
  • Turk A, Asa SL, Baloch ZW, Faquin WC, Fellegara G, Ghossein R, Giordano TJ, Livolsi V, Lloyd RV, Mete O, Rosai J, Suster S, Thompson LDR, Wenig BM. Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging. Thyroid. 2019 May.29(5):619-624. Pubmedid: 30913992.
  • Martin-Gomez L, Giuliano AR, Fulp WJ, Caudell J, Echevarria M, Sirak B, Abrahamsen M, Isaacs-Soriano KA, Hernandez-Prera JC, Wenig BM, Vorwald K, McMullen CP, Wadsworth JT, Slebos RJ, Chung CH. Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2019 May.145(5):460-466. Pubmedid: 30920604. Pmcid: PMC6537790.
  • Martin-Gomez L, Fulp WJ, Schell MJ, Sirak B, Abrahamsen M, Isaacs-Soriano KA, Lorincz A, Wenig B, Chung CH, Caudell JJ, Giuliano AR. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases. Oral Oncol. 2019 May.92:85-91. Pubmedid: 31010629. Pmcid: PMC6736648.
  • Holmes BJ, Wenig BM. Virus-associated carcinomas of the head & neck: Update from the 2017 WHO classification. Ann Diagn Pathol. 2019 Feb.38:29-42. Pubmedid: 30415111.
  • Turk AT, Wenig BM. Thyroid tumors with follicular architecture. Ann Diagn Pathol. 2019 Feb.38:51-58. Pubmedid: 30419427.
  • Franchi A, Bishop JA, Coleman H, Flucke U, Licitra LF, Pendás JLL, Stelow EB, Toner M, Weinreb I, Wenig BM, Thompson LDR. Data Set for the Reporting of Carcinomas of the Nasal Cavity and Paranasal Sinuses: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2019 Apr.143(4):424-431. Pubmedid: 30500298.
  • Thompson LDR, Magliocca KR, Andreasen S, Kiss K, Rooper L, Stelow E, Wenig BM, Bishop JA. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients. Head Neck Pathol. 2018 Oct.13(3):355-363. Pubmedid: 30291511. Pmcid: PMC6684711.
  • Rowe ME, Ozbek U, Machado RA, Yue LE, Hernandez-Prera JC, Valentino A, Qazi M, Brandwein-Weber M, Liu X, Wenig BM, Urken ML. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes. Endocr Pathol. 2018 Mar.29(1):80-85. Pubmedid: 29396810.
  • Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid. 2018 Feb.28(2):210-219. Pubmedid: 29160163. Pmcid: PMC7869885.
  • Nikiforov YE, Baloch ZW, Hodak SP, Giordano TJ, Lloyd RV, Seethala RR, Wenig BM. Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol. 2018 Aug.4(8):1125-1126. Pubmedid: 29902314. Pmcid: PMC6584712.
  • Valderrabano P, Khazai L, Thompson ZJ, Leon ME, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach. Thyroid. 2017 Oct.27(10):1277-1284. Pubmedid: 28806881. Pmcid: PMC6112164.
  • Stelow EB, Wenig BM. Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx. Head Neck Pathol. 2017 Mar.11(1):16-22. Pubmedid: 28247232. Pmcid: PMC5340728.
  • Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants. Mod Pathol. 2017 Jan.30(s1):S112-S118. Pubmedid: 28060368.
  • Hernandez-Prera J, Machado R, Asa SL, Baloch ZW, Faquin WC, Ghossein R, LiVolsi VA, Lloyd RV, Mete O, Nikiforov YE, Seethala R, Suster S, Thompson LDR, Turk A, Sadow PM, Urken ML, Wenig BM. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?. Thyroid. 2017 Dec.27(12):1498-1504. Pubmedid: 29020884.
  • Du E, Wenig BM, Su HK, Rowe ME, Haser GC, Asa SL, Baloch Z, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML. Inter-Observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma. Thyroid. 2016 Jun.26(6):816-819. Pubmedid: 27089928.
  • Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016 Aug.2(8):1023-1029. Pubmedid: 27078145. Pmcid: PMC5539411.
  • Isayeva T, Xu J, Ragin C, Dai Q, Cooper T, Carroll W, Dayan D, Vered M, Wenig B, Rosenthal E, Grizzle W, Anderson J, Willey CD, Yang ES, Brandwein-Gensler M. The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways. Mod Pathol. 2015 May.28(5):631-653. Pubmedid: 25523612.
  • Shah AA, Wenig BM, LeGallo RD, Mills SE, Stelow EB. Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma. Head Neck Pathol. 2015 Mar.9(1):85-95. Pubmedid: 25078757. Pmcid: PMC4382490.
  • Wenig BM. Pitfalls in the biopsy diagnosis of intraoral minor salivary gland neoplasms: diagnostic considerations and recommended approach. Adv Anat Pathol. 2015 Jul.22(4):280-281. Pubmedid: 26050267.
  • Wenig BM. Viral-related diseases of the head and neck. Semin Diagn Pathol. 2015 Jan.32(1):1-2. Pubmedid: 25804340.
  • Urken ML, Mechanick JI, Sarlin J, Scherl S, Wenig BM. Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists. Endocr Pathol. 2014 Sep.25(3):214-218. Pubmedid: 24292975.
  • Wenig BM. Recently described sinonasal tract lesions/neoplasms: considerations for the new world health organization book. Head Neck Pathol. 2014 Mar.8(1):33-41. Pubmedid: 24595422. Pmcid: PMC3950390.
  • Li Y, Bai S, Carroll W, Dayan D, Dort JC, Heller K, Jour G, Lau H, Penner C, Prystowsky M, Rosenthal E, Schlecht NF, Smith RV, Urken M, Vered M, Wang B, Wenig B, Negassa A, Brandwein-Gensler M. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2013 Sep.7(3):211-223. Pubmedid: 23250819. Pmcid: PMC3738758.
  • Jour G, West K, Ghali V, Shank D, Ephrem G, Wenig BM. Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases. Head Neck Pathol. 2013 Sep.7(3):224-231. Pubmedid: 23315417. Pmcid: PMC3738749.
  • Slova D, Paniz Mondolfi A, Moisini I, Levi G, Urken M, Zevallos J, Mansoor S, Khorsandi A, Bloch D, Vidhun R, Wenig B. Colonic-type adenocarcinoma of the base of the tongue: a case report of a rare neoplasm. Head Neck Pathol. 2012 Jun.6(2):250-254. Pubmedid: 21948243. Pmcid: PMC3370020.
  • Wenig BM. Undifferentiated malignant neoplasms of the sinonasal tract. Arch Pathol Lab Med. 2009 May.133(5):699-712. Pubmedid: 19415944.
  • Wenig BM. Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract. Head Neck Pathol. 2008 Jun.2(2):131-144. Pubmedid: 20614335. Pmcid: PMC2807550.
  • Bisceglia M, D'Angelo VA, Wenig BM. Endolymphatic sac papillary tumor (Heffner tumor). Adv Anat Pathol. 2006 May.13(3):131-138. Pubmedid: 16778477.
  • Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol. 2005 May.12(3):134-143. Pubmedid: 15900114.
  • Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004 Oct.28(10):1336-1340. Pubmedid: 15371949.
  • Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003 Jun.27(6):737-749. Pubmedid: 12766577.
  • Li M, Wenig BM. Adrenal oncocytic pheochromocytoma. Am J Surg Pathol. 2000 Nov.24(11):1552-1557. Pubmedid: 11075859.
  • Wenig BM. Nasopharyngeal carcinoma. Ann Diagn Pathol. 1999 Dec.3(6):374-385. Pubmedid: 10594290.
  • Aguilera NS, Uusafr M, Wenig BM, Abbondanzo SL. The blastic variant of mantle cell lymphoma arising in Waldeyer's tonsillar ring. J Laryngol Otol. 1998 Oct.112(10):991-994. Pubmedid: 10211231.
  • Wenig BM, Mafee MF, Ghosh L. Fibro-osseous, osseous, and cartilaginous lesions of the orbit and paraorbital region. Correlative clinicopathologic and radiographic features, including the diagnostic role of CT and MR imaging. Radiol Clin North Am. 1998 Nov.36(6):1241-59, xii. Pubmedid: 9884700.
  • Schafer DR, Thompson LD, Smith BC, Wenig BM. Primary ameloblastoma of the sinonasal tract: a clinicopathologic study of 24 cases. Cancer. 1998 Feb.82(4):667-674. Pubmedid: 9477098.
  • Wenig BM. Variants of squamous cell carcinoma of the upper aerodigestive tract. Anat Pathol. 1998.3:17-51. Pubmedid: 10389580.
  • Moran CA, Albores-Saavedra J, Wenig BM, Mena H. Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases. Cancer. 1997 Jan.79(2):398-402. Pubmedid: 9010114.
  • Wenig BM, Albores-Saavedra J, Buetow PC, Heffess CS. Pancreatic mucinous cystic neoplasm with sarcomatous stroma: a report of three cases. Am J Surg Pathol. 1997 Jan.21(1):70-80. Pubmedid: 8990143.
  • Thompson LD, Wenig BM, Adair CF, Shmookler BM, Heffess CS. Primary smooth muscle tumors of the thyroid gland. Cancer. 1997 Feb.79(3):579-587. Pubmedid: 9028371.
  • Barnes L, Ferlito A, Wenig BM. Laryngeal paragangliomas. A review and report of a single case. J Laryngol Otol. 1997 Feb.111(2):197-198. Pubmedid: 9102453.
  • Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol. 1997 Feb.21(2):226-234. Pubmedid: 9042291.
  • Wenig BM, Thompson LD, Frankel SS, Burke AP, Abbondanzo SL, Sesterhenn I, Heffner DK. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases. Am J Surg Pathol. 1996 May.20(5):572-587. Pubmedid: 8619422.
  • Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996 Dec.78(11):2281-2287. Pubmedid: 8940996.
  • Frankel SS, Wenig BM, Burke AP, Mannan P, Thompson LD, Abbondanzo SL, Nelson AM, Pope M, Steinman RM. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science. 1996 Apr.272(5258):115-117. Pubmedid: 8600520.
  • Hamed G, Heffess CS, Shmookler BM, Wenig BM. Amyloid goiter. A clinicopathologic study of 14 cases and review of the literature. Am J Clin Pathol. 1995 Sep.104(3):306-312. Pubmedid: 7677120.
  • Wenig BM, Vinh TN, Smirniotopoulos JG, Fowler CB, Houston GD, Heffner DK. Aggressive psammomatoid ossifying fibromas of the sinonasal region: a clinicopathologic study of a distinct group of fibro-osseous lesions. Cancer. 1995 Oct.76(7):1155-1165. Pubmedid: 8630892.
  • Wenig BM, Adair CF, Heffess CS. Primary mucoepidermoid carcinoma of the thyroid gland: a report of six cases and a review of the literature of a follicular epithelial-derived tumor. Hum Pathol. 1995 Oct.26(10):1099-1108. Pubmedid: 7557943.
  • Saltarelli MG, Fleming MV, Wenig BM, Gal AA, Mansour KA, Travis WD. Primary basaloid squamous cell carcinoma of the trachea. Am J Clin Pathol. 1995 Nov.104(5):594-598. Pubmedid: 7572822.
  • Wenig BM. Necrotizing sialometaplasia of the larynx. A report of two cases and a review of the literature. Am J Clin Pathol. 1995 May.103(5):609-613. Pubmedid: 7741108.
  • Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer. 1995 Mar.75(6):1281-1291. Pubmedid: 7882278.
  • Wenig BM, Devaney K, Bisceglia M. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer. 1995 Dec.76(11):2217-2229. Pubmedid: 8635024.
  • Klimstra DS, Wenig BM, Adair CF, Heffess CS. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol. 1995 Dec.19(12):1371-1389. Pubmedid: 7503360.
  • Gaertner EM, Davidson M, Wenig BM. The columnar cell variant of thyroid papillary carcinoma. Case report and discussion of an unusually aggressive thyroid papillary carcinoma. Am J Surg Pathol. 1995 Aug.19(8):940-947. Pubmedid: 7611541.
  • Wenig BM. Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature. Cancer. 1995 Apr.75(7):1568-1577. Pubmedid: 8826912.
  • Wenig BM. Lipomas of the larynx and hypopharynx: a review of the literature with the addition of three new cases. J Laryngol Otol. 1995 Apr.109(4):353-357. Pubmedid: 7782700.
  • Wenig BM, Abbondanzo SL, Childers EL, Kapadia SB, Heffner DR. Extranodal sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of the head and neck. Hum Pathol. 1993 May.24(5):483-492. Pubmedid: 8491488.
  • Wenig BL, Stenson KM, Wenig BM, Tracey D. Effects of plume produced by the Nd:YAG laser and electrocautery on the respiratory system. Lasers Surg Med. 1993 Jan.13(2):242-245. Pubmedid: 8464311.
  • Wenig BM, Hitchcock CL, Ellis GL, Gnepp DR. Metastasizing mixed tumor of salivary glands. A clinicopathologic and flow cytometric analysis. Am J Surg Pathol. 1992 Sep.16(9):845-858. Pubmedid: 1384375.
  • Wenig BM. Neuroendocrine tumors of the larynx. Head Neck. 1992 Jul.14(4):332-334. Pubmedid: 1517086.
  • Kuhn JJ, Wenig BM, Clark DA. Mycosis fungoides of the larynx. Report of two cases and review of the literature. Arch Otolaryngol Head Neck Surg. 1992 Aug.118(8):853-858. Pubmedid: 1642838.
  • Kuruvilla A, Wenig BM, Humphrey DM, Heffner DK. Leiomyosarcoma of the sinonasal tract. A clinicopathologic study of nine cases. Arch Otolaryngol Head Neck Surg. 1990 Nov.116(11):1278-1286. Pubmedid: 2242259.
  • Wenig BM, Heffner DK, Oertel YC, Johnson FB. Teflonomas of the larynx and neck. Hum Pathol. 1990 Jun.21(6):617-623. Pubmedid: 2351391.
  • Wenig BM, Weiss SW, Gnepp DR. Laryngeal and hypopharyngeal liposarcoma. A clinicopathologic study of 10 cases with a comparison to soft-tissue counterparts. Am J Surg Pathol. 1990 Feb.14(2):134-141. Pubmedid: 2301699.
  • Wenig BM, Harpaz N, DelBridge C. Polymorphous low-grade adenocarcinoma of seromucous glands of the nasopharynx. A report of a case and a discussion of the morphologic and immunohistochemical features. Am J Clin Pathol. 1989 Jul.92(1):104-109. Pubmedid: 2665471.
  • Wenig BM, Hyams VJ, Heffner DK. Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. Cancer. 1988 Dec.62(12):2658-2676. Pubmedid: 3056608.

Patient Comments
Overall Satisfaction
0
★★★★★
★★★★★

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments